ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
bronchitol
pharmaxis europe limited - mannitól - cystic fibrosis - hósti og kuldablöndur - bronchitol er ætlað til meðferðar við blöðrubólgu (cf) hjá fullorðnum 18 ára og eldri sem viðbótarmeðferð við bestu umönnun.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
acetylcystein mylan freyðitafla 200 mg
mylan ab* - acetylcysteinum inn - freyðitafla - 200 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
dexól saft 3 mg/ml
laboratoria qualiphar - dextromethorphanum hýdróbrómíð mónóhýdrat - saft - 3 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
broksil saft 6 mg/ml
williams & halls ehf.* - ambroxolum hýdróklóríð - saft - 6 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
piperacillin/tazobactam wh innrennslisstofn, lausn 4 g/0,5 g
williams & halls ehf. - piperacillinum natríum; tazobactamum natríum - innrennslisstofn, lausn - 4 g/0,5 g
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
túfen saft 13,33 mg/ml
laboratoria qualiphar - guaifenesinum inn - saft - 13,33 mg/ml
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
lyfnua
merck sharp & dohme b.v. - gefapixant - cough - hósti og kuldablöndur - lyfnua is indicated in adults for the treatment of refractory or unexplained chronic cough.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sínex saft 1 mg/ml
laboratoria qualiphar - bromhexinum hýdróklóríð - saft - 1 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
mucolysin freyðitafla 600 mg
sandoz a/s* - acetylcysteinum inn - freyðitafla - 600 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
pulmozyme lausn í eimgjafa 1 mg/ml
roche pharmaceuticals a/s - dornase alfa inn - lausn í eimgjafa - 1 mg/ml